Abstract
Purpose
To compare contrast-enhanced ultrasonography (CEUS)-derived time-intensity (TI) curves with histological findings in kidneys of patients affected by chronic glomerulonephritides (GN) in the early stage of disease.
Methods
Research ethics committee approval and patient written informed consent were obtained. Thirty-one patients who showed clinical and laboratory signs of GN, with preserved renal function, were consecutively enrolled. They underwent kidney CEUS, from which TI curves were obtained, and kidney biopsy. TI curves were compared with clinical data, ultrasound (US) Doppler, and histological parameters.
Results
The persistence of contrast agent signal during the wash-out phase was found to be correlated with the degree of disease activity (p = 0.016) and in particular with the presence of mesangial hyperplasia (p = 0.008). No correlation was observed between TI curves and clinical or Doppler US-derived parameters.
Conclusions
The persistence of contrast agent signal in the wash-out phase of CEUS appears to reflect a disturbance of perfusion in glomerular capillaries in the early stages of GN. We found that the histological element directly correlated with the prolonged wash-out was mesangial hyperplasia.
Sommario
Scopo
Confrontare le curve intensità-tempo (TI) derivate dallo studio ecografico con mezzo di contrasto (CEUS) con i reperti istologici dei reni in pazienti affetti da glomerulonefrite (GN) cronica nelle fasi iniziali di malattia
Metodi
Abbiamo dunque arruolato 31 pazienti con segni clinici e laboratoristici di GN e con funzione renale conservata. Costoro sono stati sottoposti a CEUS e biopsia renali. Si è quindi proceduto alla valutazione della curve TI rispetto ai parametri clinici, eco Doppler e istologici
Risultati
La persistenza del mezzo di contrasto nella fase di wash-out correla con il grado di attività di malattia, ed in particolare con la presenza di iperplasia mesangiale. Non sono state trovate correlazioni tra le curve TI ed i dati eco Doppler e clinici
Conclusioni
Nelle fasi iniziali delle GN, la persistenza del mezzo di contrasto durante la fase di wash-out sembra documentare una condizione di alterata perfusione nei capillari glomerulari, direttamente correlata all’iperplasia mesangiale
Similar content being viewed by others
References
Floege J, Amann K (2016) Primary glomerulonephritides. Lancet 387:2036–2048
Segelmark M, Hellmark T (2010) Autoimmune kidney diseases. Autoimmun Rev 9:A366–A371
Below JE, Cho ME, Austin HA (2008) Immunologic renal diseases. In: Rich R et al (eds) Clinical immunology: principles and practice, 3rd edn. Mosby, St. Louis, Mo, pp 995–1012
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G (2003) National Kidney Foundation Practice Guidelines for Chronic kidney Disease: evaluation, classification and stratifications. Ann Intern Med 139:137–147
Quaia E, Bertolotto M (2002) Renal parenchymal disease: is characterization feasible with ultrasound? Eur Radiol 12:2006–2020
Piscaglia F, Nolsøe C, Dietrich CF et al (2012) The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33(1):33–59
Correas JM, Hélénon O, Moreau JF (1999) Contrast-enhanced ultrasonography of native and transplanted kidney diseases. Eur Radiol 9:S394–S400
Farina R, Pennisi F, La Rosa M, Puglisi C, Di Benedetto A, Campisi G, Mazzone G, Ettorre GC (2007) Functional study of the transplanted kidney with power Doppler US and time/intensity curves. Radiol Med 112:64–73
Tsuruoka K, Yasuda T, Koitabashi K, Yazawa M, Shimazaki M, Sakurada T, Shirai S, Shibagaki Y, Kimura K, Tsujimoto F (2010) Evaluation of renal microcirculation by contrast-enhanced ultrasound With SonazoidTM as a Contrast Agent. Comparison between normal subjects and patients with chronic kidney disease. Int Heart J 51:176–182
Nestola M, Fuso P, Costanzi S, Ferraro PM, Riccardi L, Pompili M, Gambaro G, Gasbarrini G, Rapaccini GL (2009) Studio del rene nativo nell’adulto normale e nefropatico tramite ultrasonografia con mezzo di contrasto. SIUMB, Rome
Okayama S, Hirai T, Yamashita N, Somekawa S, Iwano M, Uemura S, Kanauchi M, Saito Y (2008) Contrast-enhanced ultrasonography with Sonazoid for evaluation of renal microcirculation. J Med Ultrason 35:183–189
Wei K, Le E, Bion JP, Coggins M, Thorpe J, Kaul S (2001) Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol 37:1135–1140
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
Rapaccini GL, Pompili M, Caturelli E, Amadei E, Aliotta A, Grattagliano A, Savini E, Anti M (1989) Real-time ultrasound guided renal biopsy in diffuse renal disease: 114 consecutive cases. Surg Endosc 3:42–45
Capuano A, Costanzi S, Peluso G, Zannoni GF, Vellone VG, Gremese E, Zoli A, Scott C, Beltrami CA, Romano G, Ferraccioli GF (2006) Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis. Arthritis Rheumatol 54:3633–3639
Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250
Austin HA, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45:544–550
Correas JM, Bridal L, Lesavre A, Méjean A, Claudon M, Hélénon O (2001) Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11:1316–1328
Lindner JR, Song J, Jayaweera AR, Sklenar J, Kaul S (2002) Microvascular rheology of definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr 15:396–403
Lidner JR, Wei K (2002) Contrast echocardiography. Curr Probl Cardiol 27(11):454–519
Forsberg F, Piccoli CW, Merton DA, Palazzo JJ, Hall AL (2007) Breast lesions: imaging with contrast-enhanced subharmonics US—initial experience. Radiology 244:718–726
van Esser S, Veldhuis WB, van Hillegersberg R, van Diest PJ, Stapper G, ElOuamari M, Borel Rinkes IH, Mali WP, van den Bosch MA (2007) Accuracy of contrast-enhanced breast ultrasound for pre-operative tumors size assessment in patients diagnosed with invasive ductal carcinoma of the breast. Cancer Imaging 7:63–68
Ridolfi F, Abbattista T, Marini F, Vedovelli A, Quagliarini P, Busilacchi P, Brunelli E (2007) Contrast enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liv Dis 39:929–935
Oldenburg A, Albrecht T (2008) Baseline and contrast-enhanced ultrasound of the liver in tumor patients. Ultraschall Med 29:488–498
Pompili M, Riccardi L, Semeraro S, Orefice R, Elia F, Barbaro B, Covino M, Grieco A, Gasbarrini G, Rapaccini GL (2008) Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Dig Liv Dis 40:206–215
Hohmann J, Albrecht T, Hoffmann CW, Wolf KJ (2003) Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol 46:147–159
Hata J, Kamada T, Haruma K, Kusunoki H (2005) Evaluation of bowel ischemia with contrast-enhanced US: initial experience. Radiology 236:712–715
Rapaccini GL, Pompili M, Orefice R, Covino M, Riccardi L, Cedrone A, Gasbarrini G (2004) Contrast-enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease. Scand J Gastroenterol 39:188–194
Leiner T, Kessels AG, Nelemans PJ, Vasbinder GB, de Haan MW, Kitslaar PE, Ho KY, Tordoir JH, van Engelshoven JM (2005) Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology 235:699–708
Hamada T, Yamauchi M, Tanaka M, Hashimoto Y, Nakai K, Suenaga K (2007) Prospective evaluation of contrast-enhanced ultrasonography with advanced dynamic flow for the diagnosis of intestinal ischaemia. Br J Radiol 80:603–608
Kalantarinia K, Okusa MD (2007) Ultrasound Contrast agents in the study of kidney function in health and disease. Drug Discov Today Dis Mech 4:153–158
Correas JM, Claudon M, Tranquart F, Hélénon AO (2006) The kidney: ultrasound with microbubble contrast agents. Ultrasound Q 22:53–66
Setola SV, Catalano O, Sandomenico F, Siani A (2007) Contrast-enhanced sonography of the kidney. Abdom Imaging 32:21–28
Schwenger V, Hinkel UP, Nahm AM, Morath C, Zeier M (2006) Real-time contrast-enhanced sonography in renal transplant recipients. Clin Transplant 20:51–54
Correas JM, Claudon M, Tranquart F, Hélénon O (2003) Contrast-enhanced ultrasonography: renal applications. J Radiol 84:2041–2054
Cokkinos DD, Antypa EG, Skilakaki M, Kriketou D, Tavernaraki E, Piperopoulos PN (2013) Contrast enhanced ultrasound of the kidneys: what is it capable of? Biomed Res Int 2013:595873
Benozzi L, Cappelli G, Granito M, Davoli D, Favali D, Montecchi MG, Grossi A, Torricelli P, Albertazzi A (2009) Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc 41:1214–1215
Mori G, Granito M, Favali D, Cappelli G (2015) Long-term prognostic impact of contrast-enhanced ultrasound and power Doppler in renal transplantation. Transplant Proc 47:2139–2141
Correas JM, Anglicheau D, Joly D, Gennisson JL, Tanter M, Hélénon O (2016) Ultrasound-based imaging methods of the kidney-recent developments. Kidney Int 90(6):1199–1210
Fiorini F, Barozzi L (2007) The role of ultrasonography in the study of medical nephropathy. J Ultrasound 10(4):161–167
Spatola L, Andrulli S (2016) Doppler ultrasound in kidney diseases: a key parameter in clinical long-term follow-up. J Ultrasound 19(4):243–250
Marzano MA, Pompili M, Rapaccini GL, Covino M, Cotroneo P, Manto A, Todaro L, Ghirlanda G, Gasbarrini G (1998) Early renal involvement in diabetes mellitus: comparison of renal Doppler US and radioisotope evaluation of glomerular hyperfiltration. Radiology 209:813–817
Gigante A, Barbano B, Di Mario F, Rosato E, Simonelli M, Rocca AR, Conti F, Ceccarelli F, Giannakakis K, Valesini G, Cianci R (2016) Renal parenchymal resistance in patients with biopsy proven glomerulonephritis: correlation with histological findings. Int J Immunopathol Pharmacol 29:469–474
Mezzano SA, Ruiz-Ortega M, Egido J (2001) Angiotensin II and renal fibrosis. Hypertension 38:635–638
Alexopulos E, Papagianni A, Stangou M, Pantzaki A, Papadimitriou M (2000) Adult-onset idiophatic nephrotic syndrome associated with pure diffuse mesangial hypercellularity. Nephrol Dial Transplant 15:981–987
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed written consent was obtained from all patients included in the study.
Rights and permissions
About this article
Cite this article
Nestola, M., De Matthaeis, N., Ferraro, P.M. et al. Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity. J Ultrasound 21, 81–87 (2018). https://doi.org/10.1007/s40477-018-0298-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40477-018-0298-1